These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

633 related items for PubMed ID: 2581999

  • 1. Alpha thalassemia changes erythrocyte heterogeneity in sickle cell disease.
    Noguchi CT, Dover GJ, Rodgers GP, Serjeant GR, Antonarakis SE, Anagnou NP, Higgs DR, Weatherall DJ, Schechter AN.
    J Clin Invest; 1985 May; 75(5):1632-7. PubMed ID: 2581999
    [Abstract] [Full Text] [Related]

  • 2. Heterogeneity of sickle cell disease as shown by density profiles: effects of fetal hemoglobin and alpha thalassemia.
    Baudin V, Pagnier J, Labie D, Girot R, Wajcman H.
    Haematologia (Budap); 1986 May; 19(3):177-84. PubMed ID: 2430866
    [Abstract] [Full Text] [Related]

  • 3. Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia.
    Embury SH, Dozy AM, Miller J, Davis JR, Kleman KM, Preisler H, Vichinsky E, Lande WN, Lubin BH, Kan YW, Mentzer WC.
    N Engl J Med; 1982 Feb 04; 306(5):270-4. PubMed ID: 6172710
    [Abstract] [Full Text] [Related]

  • 4. The interaction of alpha-thalassemia and homozygous sickle-cell disease.
    Higgs DR, Aldridge BE, Lamb J, Clegg JB, Weatherall DJ, Hayes RJ, Grandison Y, Lowrie Y, Mason KP, Serjeant BE, Serjeant GR.
    N Engl J Med; 1982 Jun 17; 306(24):1441-6. PubMed ID: 6176865
    [Abstract] [Full Text] [Related]

  • 5. Intracellular polymerization of sickle hemoglobin: disease severity and therapeutic goals.
    Noguchi CT, Rodgers GP, Schechter AN.
    Prog Clin Biol Res; 1987 Jun 17; 240():381-91. PubMed ID: 3615501
    [Abstract] [Full Text] [Related]

  • 6. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
    Rodgers GP, Dover GJ, Uyesaka N, Noguchi CT, Schechter AN, Nienhuis AW.
    N Engl J Med; 1993 Jan 14; 328(2):73-80. PubMed ID: 7677965
    [Abstract] [Full Text] [Related]

  • 7. Individual variation in the production and survival of F cells in sickle-cell disease.
    Dover GJ, Boyer SH, Charache S, Heintzelman K.
    N Engl J Med; 1978 Dec 28; 299(26):1428-35. PubMed ID: 101847
    [Abstract] [Full Text] [Related]

  • 8. Concurrent sickle cell anemia and alpha-thalassemia. Effect on pathological properties of sickle erythrocytes.
    Embury SH, Clark MR, Monroy G, Mohandas N.
    J Clin Invest; 1984 Jan 28; 73(1):116-23. PubMed ID: 6690472
    [Abstract] [Full Text] [Related]

  • 9. Hematologically and genetically distinct forms of sickle cell anemia in Africa. The Senegal type and the Benin type.
    Nagel RL, Fabry ME, Pagnier J, Zohoun I, Wajcman H, Baudin V, Labie D.
    N Engl J Med; 1985 Apr 04; 312(14):880-4. PubMed ID: 2579336
    [Abstract] [Full Text] [Related]

  • 10. Lack of influence of fetal hemoglobin levels or erythrocyte indices on the severity of sickle cell anemia.
    Powars DR, Schroeder WA, Weiss JN, Chan LS, Azen SP.
    J Clin Invest; 1980 Mar 04; 65(3):732-40. PubMed ID: 6153392
    [Abstract] [Full Text] [Related]

  • 11. Alpha-thalassemia changes the cell density profile in sickle cell anaemia.
    Tejuca M, Martinez G, Ferreira R, Hernández A, Ferrer L, Goicochea A, Hernández AC, Coyula R, Wade M, Colombo B.
    Haematologia (Budap); 1989 Mar 04; 22(3):175-80. PubMed ID: 2583597
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. alpha-Thalassemia and HbF concentration in sickle cell anemia.
    Rucknagel D, Ferrucci S, Whitten CF, Sarniak I, Odenheimer D, Sing C, Bruzdzinski C.
    Prog Clin Biol Res; 1984 Mar 04; 165():103-20. PubMed ID: 6209727
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of alpha-thalassemia-2 on the developmental changes of hematological values in children with sickle cell disease from Georgia.
    Felice AE, McKie KM, Cleek MP, Marino EM, Kutlar A, McKie VC.
    Am J Hematol; 1987 Aug 04; 25(4):389-400. PubMed ID: 2441597
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Sickle cell syndromes. III. Silent-carrier alpha-thalassemia in combination with hemoglobin S and hemoglobin C.
    Honig GR, Mason RG, Tremaine LM, Vida LN.
    Pediatr Res; 1979 Oct 04; 13(10):1109-11. PubMed ID: 503635
    [Abstract] [Full Text] [Related]

  • 19. Intracellular Ca(2+)-containing vesicles in sickle cell disorders.
    Westerman MP, Puchulu E, Schlegel RA, Salameh M, Williamson P.
    J Lab Clin Med; 1994 Sep 04; 124(3):416-20. PubMed ID: 8083584
    [Abstract] [Full Text] [Related]

  • 20. Beta-S gene cluster haplotypes modulate hematologic and hemorheologic expression in sickle cell anemia. Use in predicting clinical severity.
    Powars DR, Meiselman HJ, Fisher TC, Hiti A, Johnson C.
    Am J Pediatr Hematol Oncol; 1994 Feb 04; 16(1):55-61. PubMed ID: 7508688
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.